The company's services include the whole chain of sample handling, from logistics to sample preparation, to reporting by a pathologist.
Inify became independent in 2022 through a spin-off from ContextVision, with 40 years of experience within digital imaging for medical applications.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze